Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)

TADAWUL:2070 Cash Flow Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	178.61	184.36	24.54	-50.73	-165.14	26.45
Depreciation & Amortization	84.84	86.85	78.84	76.19	84.93	83.66
Other Amortization	10.27	10.27	5.86	5.82	3.89	4.44
Loss (Gain) From Sale of Assets	-10.35	-28.7	-18.94	-6.38	-0.14	0.45
Asset Writedown & Restructuring Costs	2.68	2.68	17.37	0.05	-	-
Loss (Gain) From Sale of Investments	25.47	21.3	37.06	42.05	-3.63	-7.81
Loss (Gain) on Equity Investments	-23.81	-24.35	-22.73	-20	-20.44	-11.41
Stock-Based Compensation	0.94	1.71	1.18	-	-	-
Provision & Write-off of Bad Debts	-	-	-	-	10.05	-13.86
Other Operating Activities	-21.19	13.16	-73.92	160.41	11.05	-6.84
Change in Accounts Receivable	121.21	-23.18	-341.48	-190.08	172.69	18.02
Change in Inventory	23.59	25.78	-49.6	-143.03	-76.56	13.02
Change in Accounts Payable	-75.23	-59.39	116.37	128.35	-57.96	-14.27
Change in Other Net Operating Assets	50.56	61.89	-105.5	8.22	-44.37	-3
Operating Cash Flow	365.28	272.35	-330.96	10.87	-99.3	86.71
Operating Cash Flow Growth	-	-	-	-	-	790.67%
Capital Expenditures	-82.3	-89.14	-71.27	-106.79	-78.21	-76.24
Sale of Property, Plant & Equipment	13.39	39.55	35.55	7.53	0.65	1.02
Sale (Purchase) of Intangibles	-10.57	-10.44	-31.01	-5.94	-	-1
Investment in Securities	-16.45	-24.98	-39.5	-70.5	525.89	193.74
Other Investing Activities	-	-	13.19	8.75	36.3	23.97
Investing Cash Flow	-95.93	-85.01	-93.05	-166.94	484.63	141.48
Long-Term Debt Issued	-	1,612	1,290	1,497	-	14.47
Long-Term Debt Repaid	-	-1,717	-894.41	-1,462	-220.55	-81.35
Net Debt Issued (Repaid)	-289.81	-104.78	395.82	34.61	-220.55	-66.87
Repurchase of Common Stock	-	-	-11.94	-8	-	-
Common Dividends Paid	-	-	-2.78	-0.46	-70.74	-118.11
Other Financing Activities	0.96	0.87	-	-26.19	-49.86	-55.97
Financing Cash Flow	-288.85	-103.91	381.11	-0.04	-341.15	-240.95
Foreign Exchange Rate Adjustments	2.75	-1.67	1.95	-16.15	-38.5	8.35
Net Cash Flow	-16.75	81.76	-40.95	-172.26	5.69	-4.42
Free Cash Flow	282.98	183.21	-402.23	-95.92	-177.51	10.47
Free Cash Flow Margin	17.20%	10.73%	-23.91%	-5.79%	-12.48%	0.72%
Free Cash Flow Per Share	2.38	1.53	-3.37	-0.80	-1.48	0.09
Cash Interest Paid	72.3	72.3	108.15	69.82	33.41	20.26
Cash Income Tax Paid	-	-	-	-	-	0.54
Levered Free Cash Flow	210.53	96.42	-353.95	41.76	-121.09	-56.73
Unlevered Free Cash Flow	263.12	152.06	-299.72	81.45	-99.63	-37.11
Change in Working Capital	117.83	5.09	-380.21	-196.54	-6.2	13.78

Source: S&P Global Market Intelligence. Standard template. Financial Sources.